Pancreatic Cancer Screening in High-Risk Individuals Pancreatic Cancer Screening in High-Risk Individuals
The USPSTF has upheld its'do not screen'recommendation for pancreatic cancer in the general population, but experts argue for screening for high-risk individuals.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 19, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Should PARP Inhibitors Have Tumor-Agnostic Approval Status? Should PARP Inhibitors Have Tumor-Agnostic Approval Status?
We have strong data for the benefits of PARP inhibitors in metastatic cancers in the presence of germline BRCA mutations, but is it enough to drive their tumor-agnostic approval?Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 19, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Obesity Effect on Cancer Risk Twice That Currently Thought Obesity Effect on Cancer Risk Twice That Currently Thought
A new analysis of genetic data suggests that the effect of obesity on cancer risk is much higher than currently estimated from observational studies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 16, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves Fedratinib for the Treatment of Myelofibrosis FDA Approves Fedratinib for the Treatment of Myelofibrosis
The second drug for myelofibrosis has now been approved, giving patients another option.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 16, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves Another Tumor-Agnostic Cancer Drug FDA Approves Another Tumor-Agnostic Cancer Drug
Entrectinib is indicated for the treatment of solid tumors expressing NTRK+ in adults and children, and also for the treatment of metastatic, ROS1-positive non-small cell lung cancerFDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 16, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Practice Change? Weight Loss Advice for Breast Cancer Lymphedema Practice Change? Weight Loss Advice for Breast Cancer Lymphedema
In a surprising finding, a weight loss and home-based exercise program did not reduce lymphedema symptoms in breast cancer survivors. The authors say this should change clinical guidelines.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Treatment Success in Lung Cancer Is More Than Survival Treatment Success in Lung Cancer Is More Than Survival
Patients with advanced lung cancer view treatment success as improving their survival plus maintaining a good quality of life and function.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Treatment Success More Than Survival in Lung Cancer Treatment Success More Than Survival in Lung Cancer
Patients with advanced lung cancer view treatment success as improving their survival plus maintaining a good quality of life and function.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Time to Rethink Treating Brain Metastases in NSCLC? Time to Rethink Treating Brain Metastases in NSCLC?
Dr Jack West on how immunotherapy has opened up new potential for intracranial disease control.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Living With Metastatic Breast Cancer: 5 Things to Know Living With Metastatic Breast Cancer: 5 Things to Know
As patients with metastatic breast cancer are living longer, clinicians should have an understanding of their needs for better quality of life. Start with these five key facts.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Article Source Type: news

Decision Aid Improves Management of Febrile Neutropenia Decision Aid Improves Management of Febrile Neutropenia
Clinical decision aid helps improve adherence to best practice guidelines for febrile neutropenia management in oncology patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 13, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Data Suggest Earlier Olaparib for BRCA+ Ovarian Cancer New Data Suggest Earlier Olaparib for BRCA+ Ovarian Cancer
Results of the SOLO3 trial show that the PARP inhibitor olaparib is a promising strategy for recurrent ovarian cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 13, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Setbacks and Advances in Renal Cell Carcinoma Treatment Setbacks and Advances in Renal Cell Carcinoma Treatment
Although we have more evidence against tyrosine kinase inhibitors in the adjuvant setting, studies on immunotherapy and surveillance point toward progress.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 13, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

New Option for VTE Cancer Prophylaxis -- DOACs New Option for VTE Cancer Prophylaxis -- DOACs
Updated clinical guidelines allow -- for the first time -- the use of direct oral anticoagulants as a treatment option for cancer patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 12, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Should All Breast Cancer Patients Undergo Genetic Testing? Should All Breast Cancer Patients Undergo Genetic Testing?
Experts on both side of the issue weigh in on whether all women with breast cancer should be tested using expanded panel genetic testing.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 9, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

De-escalating Cancer Therapy: More Talk Than Action? De-escalating Cancer Therapy: More Talk Than Action?
Dr Ravi Parikh on what it will take to move de-escalation from'lip service'to a substantial field of research.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 8, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Medicare Announces Coverage for CAR T-Cell Therapy Medicare Announces Coverage for CAR T-Cell Therapy
The Centers for Medicare& Medicaid Services has issued a national coverage decision for the costly customized cancer therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 8, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA OKs Oral Ferric Maltol for Iron Deficiency in Adults FDA OKs Oral Ferric Maltol for Iron Deficiency in Adults
Accrufer might lessen the need for patients to progress to intravenous iron therapy, leading to a change in the current paradigm for the treatment of iron deficiency anemia, the company said.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 8, 2019 Category: Cancer & Oncology Tags: Gastroenterology News Alert Source Type: news

Bacteremia May Be Sign of Opioid Theft, Says Cancer Hospital Bacteremia May Be Sign of Opioid Theft, Says Cancer Hospital
A cluster of a specific type of bacteremia may be a signal that narcotics theft is occurring at a hospital, warns staff from Roswell Park Comprehensive Cancer Center in Buffalo, New York.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 7, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Hospital Says Bacteremia May Be Sign of Opioid Theft Cancer Hospital Says Bacteremia May Be Sign of Opioid Theft
A cluster of a specific type of bacteremia may be a signal that narcotics theft is occurring at a hospital, warns staff from Roswell Park Comprehensive Cancer Center in Buffalo, New York.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 7, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Half of NCI Cancer Center Directors Collect Industry Payments Half of NCI Cancer Center Directors Collect Industry Payments
Some of the payments were for more than $5000, and one director pocketed $2.27 million in 2017. Is this in the public interest?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 7, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Long-term Data Suggest'Functional Cure' in Advanced Cancer Long-term Data Suggest'Functional Cure' in Advanced Cancer
Long-term survival data from one of the first trials conducted with nivolumab show that some patients are living for years, suggesting a'functional cure at least'say the authors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 6, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Functional Cure' in Advanced Cancer Suggested by Long-term Data'Functional Cure' in Advanced Cancer Suggested by Long-term Data
Long-term survival data from one of the first trials conducted with nivolumab show that some patients are living for years, suggesting a'functional cure at least'say the authors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 6, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Survival Linked to Antidepressant Adherence Cancer Survival Linked to Antidepressant Adherence
A study of more than 42,000 patients provides the first data showing that patients with cancer who took their antidepressants as prescribed survived longer. Experts, however, remain unconvinced.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 5, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Patients Report Lack of Info and Support Cancer Patients Report Lack of Info and Support
Patients with cancer should be listened to, say authors of an international survey that highlights where patients feel least supported.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 2, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Bevacizumab Benefit in Large-Volume Ovarian Cancer Bevacizumab Benefit in Large-Volume Ovarian Cancer
Although there was no benefit in overall survival in the primary treatment of ovarian cancer with maintenance bevacizumab, some hope remains for patients with large-volume disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 1, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Don't Stop Using DRE With Prostate Cancer Patients Don't Stop Using DRE With Prostate Cancer Patients
The low-tech, low-cost digital rectal exam still has value — as a prognostic tool in men with prostate cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 31, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First Approval for Immunotherapy for Esophageal Cancer First Approval for Immunotherapy for Esophageal Cancer
Esophageal cancer has now joined the list of tumor types that can be treated with a checkpoint inhibitor — in this case, with pembrolizumab (Keytruda).FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 31, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

' A Really Big Year' for Lung Cancer Treatment'A Really Big Year' for Lung Cancer Treatment
Dr Mark Kris reviews promising new research in neoadjuvant and adjuvant therapies for lung cancer, presented at ASCO 2019.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 30, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Patients Turn to Crowdfunding to Help Pay for CAR-T Cell Therapy Patients Turn to Crowdfunding to Help Pay for CAR-T Cell Therapy
Patients are turning to crowdfunding campaigns to help pay for CAR-T cell therapy, both for the product and for indirect costs such as travel and accommodation.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 30, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Chemo Doesn't Turn'Cold' Tumors'Hot': Debunking a Myth Chemo Doesn't Turn'Cold' Tumors'Hot': Debunking a Myth
David Kerr comments on a new article in Annals of Oncology that attempts to debunk the myth that treating tumors with cytotoxic chemotherapy renders tumors more responsive to immunotherapy.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 29, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

In Breast Cancer, Delay Between Surgery and Chemo Harms Survival In Breast Cancer, Delay Between Surgery and Chemo Harms Survival
There is'room for improvement'in having women undergo adjuvant chemotherapy, say authors of a large study that found delays with reconstruction after mastectomy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 29, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pediatric Lymphoma Joins Family of BRCA2 Cancers Pediatric Lymphoma Joins Family of BRCA2 Cancers
Researchers call for genetic testing of all survivors of pediatric non-Hodgkin lymphoma after data revealed BRCA2 is implicated in the childhood disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 26, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

EU OK for First'Histology-Independent' Cancer Drug EU OK for First'Histology-Independent' Cancer Drug
The first so-called histology-independent cancer treatment has been recommended for approval in the European Union.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 26, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

High Response Rate With First Targeted Drug for Bladder Cancer High Response Rate With First Targeted Drug for Bladder Cancer
The novel targeted drug is welcomed by experts as an option in the second-line treatment of patients with metastatic bladder cancers and FGFR genetic alterations.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 25, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Ovarian Cancer Risk Influenced by Vaginal Microbiome? Ovarian Cancer Risk Influenced by Vaginal Microbiome?
Could lower levels of protective bacteria in the vaginal microbiota increase the risk of ovarian cancer? The association was seen only in younger women, and not in those aged 50 or older.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 24, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Allergan Pulls Textured Breast Implants in US and Worldwide Allergan Pulls Textured Breast Implants in US and Worldwide
The recall comes after an increase in reports of breast implant-associated anaplastic large cell lymphoma; the FDA says 573 unique cases and 33 deaths have been reported worldwide.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 24, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Shape Matters: Normal BMI Apples, Olives Fare Worse Than Pears Shape Matters: Normal BMI Apples, Olives Fare Worse Than Pears
Apple vs pear vs olive-on-a-stick: the"scale is not everything." New study underscores the importance of waist circumference for mortality risk even when weight is normal, extends prior observations.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 24, 2019 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

Could TNF Blocker Cure Immunotherapy-Induced Diabetes? Could TNF Blocker Cure Immunotherapy-Induced Diabetes?
Case report points to possible novel therapeutic approach to an increasingly common side effect of successful cancer therapy with immune checkpoint inhibitors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 23, 2019 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

Exceeding Our Patients' Expectations Needs to Be the Goal Now Exceeding Our Patients' Expectations Needs to Be the Goal Now
Merely meeting expectations is not good enough anymore, says Dr Mark Kris. We are poised to cure some cancers and give our patients'lives back to them. We should not hesitate to do it.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 23, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

10 Ways to Improve the Value of Cancer Care 10 Ways to Improve the Value of Cancer Care
David Kerr comments on a list of 10 recommendations from Choosing Wisely India on how to improve the value of cancer care.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 23, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

What Matters Most to Oncology Patients? What Matters Most to Oncology Patients?
Lidia Schapira talks with Ethan Basch, a leading investigator of patient-reported outcomes, on better ways to track patients'symptoms.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 22, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Many Common, Deadly Cancers Underfunded by Nonprofits Many Common, Deadly Cancers Underfunded by Nonprofits
Many common, deadly cancers are underfunded by nonprofit organizations; these cancers affect parts of the body that are stigmatized, and this may be contributing, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Biden Cancer Initiative Hits'Pause'Biden Cancer Initiative Hits'Pause '
The organization has suspended operations while the former vice president conducts his 2020 campaign for president.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Is the'Value' Movement Affecting Everyday Oncology Practice? Is the'Value' Movement Affecting Everyday Oncology Practice?
' It's finally starting to happen.'Drs Miller, Saltz, and Schwartzberg discuss how the concept of value is both changing and challenging the cancer care community.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Problem Persists: Overtreatment of Thyroid Cancer With RAI Problem Persists: Overtreatment of Thyroid Cancer With RAI
A new study underscores concerns about overtreatment of patients with low-risk thyroid cancer with radioactive iodine, which exposes them to unnecessary risks.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Framework Ranks'Actionability' of Genetic Mutations Framework Ranks'Actionability' of Genetic Mutations
Dr David Kerr discusses the use of the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) for determining the level of evidence for actionability of genomic alterations.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Algorithm Could Be'Major Leap Forward' for Pancreatic Cysts Algorithm Could Be'Major Leap Forward' for Pancreatic Cysts
Machine-learning trains algorithm to classify pancreatic cysts into low to high risk, potentially sparing patients'unnecessary complex surgery to remove lesions with no malignant potential.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

CMS Proposes New Bundled Payment Model for Radiation Oncology CMS Proposes New Bundled Payment Model for Radiation Oncology
CMS has proposed a new mandatory radiation oncology model, which would bundle payments for treatments that span a 90-day episode.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Skipping Surgery in Rectal Cancer: Better or Worse? Skipping Surgery in Rectal Cancer: Better or Worse?
' Unreliable'assessment of complete clinical response after neoadjuvant chemoradiotherapy for rectal cancer means a watch-and-wait strategy should be followed with caution, suggest results of an expert debate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 17, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news